O. Reg. 499/05: GENERAL, Filed September 22, 2005 under Ontario Drug Benefit Act, R.S.O. 1990, c. O.10
ontario regulation 499/05
made under the
ontario drug benefit act
Made: September 21, 2005
Filed: September 22, 2005
Printed in The Ontario Gazette: October 8, 2005
Amending O. Reg. 201/96
(General)
1. Section 1 of Ontario Regulation 201/96 is amended by adding the following subsection:
(7) For the purposes of this Regulation, items 392, 393, 394, 395, 396, 398, 1158, 1285, 1286 and 1287 of Part III of the Formulary shall be read as follows:
392 |
2265273 |
Novo-Warfarin 1mg Tab |
393 |
2265281 |
Novo-Warfarin 2mg Tab |
394 |
2265303 |
Novo-Warfarin 2.5mg Tab |
395 |
2265311 |
Novo-Warfarin 3mg Tab |
396 |
2265338 |
Novo-Warfarin 4mg Tab |
398 |
2265346 |
Novo-Warfarin 5mg Tab |
1158 |
2246083 |
Apo-Ipravent 0.03% Nasal Spray |
1285 |
2245456 |
Sodium Aurothiomalate 10mg/mL Inj Sol-1mL Pk |
1286 |
2245457 |
Sodium Aurothiomalate 25mg/mL Inj Sol-1mL Pk |
1287 |
2245458 |
Sodium Aurothiomalate 50mg/mL Inj Sol-1mL Pk |
2. The Regulation is amended by adding the following section:
7.2 A drug product identified by brand name and manufacturer in the following amendments to Part III of the Formulary is designated as a listed drug product unless there is an indication in that Part that the drug product is not a benefit:
1. Amendments dated September 30, 2005.
3. (1) Subject to subsection (2), this Regulation comes into force on September 27, 2005.
(2) Section 2 comes into force on the later of,
(a) September 30, 2005; and
(b) the day that is 10 days after the day of filing, where the following are not included in calculating the 10 days:
(i) the day of filing, and
(ii) Saturdays and Sundays and other holidays within the meaning of the Interpretation Act.
Made by:
George Smitherman
Minister of Health and Long-Term Care
Date made: September 21, 2005.